FR2294696A1 - Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications - Google Patents

Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications

Info

Publication number
FR2294696A1
FR2294696A1 FR7539194A FR7539194A FR2294696A1 FR 2294696 A1 FR2294696 A1 FR 2294696A1 FR 7539194 A FR7539194 A FR 7539194A FR 7539194 A FR7539194 A FR 7539194A FR 2294696 A1 FR2294696 A1 FR 2294696A1
Authority
FR
France
Prior art keywords
substd
alkyl
opt
tri
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7539194A
Other languages
English (en)
Other versions
FR2294696B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2294696A1 publication Critical patent/FR2294696A1/fr
Application granted granted Critical
Publication of FR2294696B1 publication Critical patent/FR2294696B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7539194A 1974-12-21 1975-12-19 Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications Granted FR2294696A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460990 DE2460990A1 (de) 1974-12-21 1974-12-21 Neue prostaglandin-analoga und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2294696A1 true FR2294696A1 (fr) 1976-07-16
FR2294696B1 FR2294696B1 (fr) 1978-07-28

Family

ID=5934352

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7539194A Granted FR2294696A1 (fr) 1974-12-21 1975-12-19 Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications

Country Status (11)

Country Link
JP (1) JPS5186449A (fr)
AU (1) AU8772775A (fr)
BE (1) BE836950A (fr)
DE (1) DE2460990A1 (fr)
DK (1) DK581075A (fr)
ES (1) ES443524A1 (fr)
FR (1) FR2294696A1 (fr)
LU (1) LU74076A1 (fr)
NL (1) NL7514654A (fr)
SE (1) SE7514447L (fr)
ZA (1) ZA757872B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212985A (en) * 1978-04-28 1980-07-15 The Upjohn Company cis-4,5-Didehydro-16-phenoxy-PGE1 compounds
US6107338A (en) * 1997-09-09 2000-08-22 The Procter & Gamble Company Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
NZ503735A (en) * 1997-09-09 2001-05-25 Procter & Gamble Aromatic C16-20-substituted tetrahydro prostaglandin F analogues useful as FP agonists
CN1269784A (zh) * 1997-09-09 2000-10-11 普罗克特和甘保尔公司 用作fp激活剂的芳香族c16－c20－取代四氢***素
US6444840B1 (en) 1998-03-31 2002-09-03 The Procter & Gamble Co. C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
IL138446A0 (en) 1998-03-31 2001-10-31 Procter & Gamble C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
WO2011014649A1 (fr) 2009-07-29 2011-02-03 Duke University Compositions et procédés destinés à inhiber la croissance des poils

Also Published As

Publication number Publication date
SE7514447L (sv) 1976-06-22
FR2294696B1 (fr) 1978-07-28
ES443524A1 (es) 1977-05-01
DE2460990A1 (de) 1976-07-01
ZA757872B (en) 1976-11-24
DK581075A (da) 1976-06-22
AU8772775A (en) 1977-06-23
BE836950A (fr) 1976-06-22
JPS5186449A (fr) 1976-07-29
LU74076A1 (fr) 1976-11-11
NL7514654A (nl) 1976-06-23

Similar Documents

Publication Publication Date Title
FR2294696A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications
IT1121462B (it) Derivati dell acido dl 9 cheto prosta trienoico particolarmente utili come medicamenti e procedimento per la loro preparazione
ES8604179A1 (es) Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
ES8406479A1 (es) Procedimiento de preparacion de derivados de yantina como divisional de la solicitud de patente de invencion numero 515.936,solicitada el 24 de septiembre de 1982)(como divisional de la patente numero 515.936)
IE33477L (en) Naphthacene derivatives
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
GB1458315A (en) Prostanoic acid derivatives
FR2301240A1 (fr) Analogues d'acides prostanoiques, leur procede de preparation et leurs applications
US3829579A (en) Stable solutions of pge-type compounds
IT1059533B (it) Composti mono cromonici ad attiviata farmacologica processo per la loro preparazione e composizioni contenenti detti composti monocromonici
ES531131A0 (es) Un procedimiento para preparar acido 5r,6s,8r-6-(1-hidroxietil)-2-(2-carbamoiloxietiltio)-penem-3-carboxilico
SE8104703L (sv) Hetero-prostaglandinderivat och forfaranden for framstellning derav
GB1388041A (en) Benzimidazolyl sulphides and sulphones
GB1389069A (en) Prostaglandins and the preparation thereof
SE8106300L (sv) Medel i synnerhet for bladfellning pa plantor
IT1085878B (it) Bicilicli ossiranici 15-cheto-prostenoici acidi
IT1115636B (it) 13,14-deidro-bicicliche prostaglandine
IT1075678B (it) 15-idrossi-bicicliche prostaglandine
IT1072541B (it) 6(9)-ossido-prostenoici acidi
GB1464206A (fr)
PT71891A (en) Process for the preparation of new 16-methoxy-16-methyl-prostaglandin e1 derivatives useful as gastroprotective agents
IT1120412B (it) Tiaprostaglandine e procedimento per la loro produzione
GB736371A (en) Improvements in or relating to methods of producing stable aqueous solutions containing vitamin b
ES8604507A1 (es) Procedimiento de preparacion de las prostaglandinas del tipo 12-epi-pgf2b

Legal Events

Date Code Title Description
ST Notification of lapse